Home » Topics » BioWorld Science

BioWorld Science
RSS

Aramchol shows effects in preclinical models of lung and gastrointestinal fibrosis

July 8, 2022

Explant glioblastoma model may allow early precision treatment of patients

July 8, 2022

Novel vaccination strategy using AMP-CpG against EBV infection shows promise in vivo

July 8, 2022

New ROCK-1/2 inhibitors identified at Chiesi Farmaceutici

July 8, 2022

Shanghai Institute of Materia Medica describes thyroid hormone receptor agonists

July 8, 2022

New pantetheinase inhibitors discovered at Shanghai Meiyue Biotech Development

July 8, 2022

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group present SLC9A3 inhibitors

July 8, 2022

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical patents ADCs targeting B7-H3

July 8, 2022

Novel microRNA panel predicts immunotherapy efficacy in NSCLC

July 8, 2022

BRCA1 methylation, mutation portend different response to chemotherapy

July 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...